Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending April 7, 2003. The report is a notification of changes in director interests regarding the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on a specific transaction within the GlaxoSmithKline US Retirement Savings Plan.
Material Changes
- Retirement Plan Holdings: The number of Ordinary Share ADRs held by the GlaxoSmithKline US Retirement Savings Plan decreased from 18,642,142 to 18,586,757.
- Transaction Date: The movement occurred on April 4, 2003.
- Average Price: The shares were transacted at an average price of $36.89.
Management Commentary and Risks
The filing notes that the Plan is a discretionary fund for current and former employees. Dr. J P Garnier, a director of the company, is potentially interested in the shares held in the fund in the same manner as other employees. No other risks, contingencies, or unusual items are disclosed in this text.
Investor Verification Points
- Verify the total impact of the 55,385 share decrease on the overall director ownership reporting.
- Confirm if this transaction represents a routine fund rebalancing or a specific strategic adjustment.
- Check subsequent filings for any further changes in Dr. Garnier's direct or indirect holdings.